Scientific Revolutions: New Therapies Meet New Biology

3:00 PM - 4:00 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 253ABC
How have new understandings of cell biology, genomics, AI/ML based platform technologies expanded the druggable space to address hard-to-hit targets? What are the strategies and cutting edge/next generation biotech platforms that are being developed to push the current scientific boundaries and further expand the druggable space?
Institute Professor
MIT and Intramural Faculty, Koch institute for Integrative Cancer Research
Chief Scientific Officer
Dewpoint Therapeutics
Professor of Biology
MIT and Core Member, Whitehead Institute
Beam Therapeutics
Associate Professor of Pediatric Oncology; Harvard Medical School, Affiliate Faculty of Biological Chemistry and Molecular Biology; Institute Member and Epigenomics Program Co-Director
Dana-Farber Cancer Institute; Harvard Medical School; Broad Institute of MIT and Harvard